Taylor Morrison Home Corporation (NYSE: TMHC) — Warren Buffett Buys the Cheapest Top-5 Builder at the Bottom of Its Own Range

Independent equity research — event-driven note. Report date: July 11, 2026. Price reference: $71.85 (close 2026-07-10). Event: pending all-cash acquisition by Berkshire Hathaway at $72.50/share (agreement dated May 31, 2026).

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information — not investment advice. The analysis that follows carries no recommendation and no price target; it discusses valuation only as embedded expectations, deal mechanics, and scenarios. The position, framing, and valuation zone here are the author’s alone.

Verdict: HOLD / tender into the deal — this is no longer a fundamental call, it is a merger-arbitrage position with a hard ceiling of $72.50. At $71.85 you are being offered a ~0.9% gross spread to a board-approved, all-cash, no-financing-condition Berkshire Hathaway take-private that is very likely to close in Q3 2026. Not a fundamental buy (upside is capped), not a short (Berkshire, robust market-check, unanimous board). Conviction the deal closes: high. Conviction on the ~0.9% spread being worth capturing: an arbitrageur’s call, not an investor’s.

The fundamental report I set out to write — “the cheapest way to own a top-5 U.S. homebuilder: a disciplined buyback machine that shrank its share count ~25% in five years, trading at 1.1x book and ~11x earnings for a 16% ROE while peers like Toll fetch 1.7x” — has been rendered moot by the fact that Warren Buffett agrees with it and bought the whole thing. On May 31, 2026, Berkshire Hathaway signed to acquire TMHC for $72.50/share in cash, ~24% above the unaffected $58.50 close. That is Buffett’s archetype trade: a well-run, out-of-favor cyclical with a fortress balance sheet and a genuinely excellent operator (Sheryl Palmer), taken private for cash at ~1.11x book, ~1.23x tangible book, ~9.3x trailing EPS, and only ~15x management’s own trough-year (2026E) forecast — against a five-year plan the board’s bankers were shown that reaches ~$15 of EPS by 2030. He is buying the recovery, not the trough, and paying a trough-cycle multiple to do it. The irony worth stating plainly: the “TMHC is too cheap versus its peers” variant was correct, and the reward for being right is a cash check, not the re-rating.

So the only live question is the spread and the close, and both point the same way. The consideration is all cash with no financing condition; the sole gating approval is HSR antitrust, where Berkshire’s homebuilding footprint (Clayton’s manufactured housing, HomeServices brokerage, building-products units) barely overlaps a production builder; the board was unanimous on two independent fairness opinions (Goldman Sachs and Moelis); and the price emerged from a genuine market-check — a rival $71.00 cash-and-stock bid (Party A) plus a canvass of six other parties, none of whom topped Berkshire’s “best and final” $72.50. The stock is pinned at $71.85, and the June sell-side “downgrades” to Peer/Market-Perform are deal-pinning, not fundamental bearishness — there is simply no upside left above the cash price. The tell that this is genuinely cheap and not a lowball: shareholders who owned TMHC at its ~$74.80 high in November 2024 are being cashed out ~3% below where the stock traded eighteen months earlier, yet a full auction still could not produce a higher bid — which tells you the standalone equity had de-rated hard on affordability, and Berkshire is capturing that de-rate.

Tag: “The market said this builder was too cheap; Buffett settled the argument with a checkbook.”

What flips the arb view: a topping bid (very unlikely — the market was already checked and Berkshire’s balance sheet is unmatchable) would raise the ceiling; an HSR second request or a Berkshire walk (both low-probability) is the downside, which resets the stock toward the ~$58–60 unaffected level (~−17%). What would have flipped the fundamental call bullish (now academic): durable mid-20s% Esplanade-led gross margins proving the mid-teens ROE is structural, not cyclical. Bearish: the ~20.6% Q1-2026 gross margin marking the start of a deeper affordability-driven margin reset — which is precisely the trough Berkshire is buying.

📈 Stock Price Action — Five-Year Event Map

Text-only by design. The price move is a Fact; the attributed cause is Interpretation. No price target, no support/resistance, no chart-pattern reading. Prices are split/dividend-adjusted (AZI 5-year CSV).

The arc. Over the trailing ~60 months Taylor Morrison ran a full homebuilder cycle and ended it inside a merger. The adjusted close bottomed at a rate-shock low of ~$20.7 (17-Jun-2022), compounded more than 3.5x to a cyclical high of ~$74.80 (25-Nov-2024), then de-rated through 2025 on affordability pressure into a $54–67 range, printing an unaffected $58.50 on 29-May-2026. On 1-Jun-2026 it gapped to ~$71.55 (+22%) on the announcement of Berkshire Hathaway’s $72.50/share all-cash acquisition, and it has traded pinned just below the cash price since — $71.85 today, inside a 52-week range of ~$54.79 (15-May-2026) to ~$71.98 (25-Jun-2026), i.e. ~0.9% below the deal consideration. The defining feature of the five-year chart: the stock traded above the eventual $72.50 takeout price during the 2024 boom, then a full auction eighteen months later still cleared at $72.50 — a measure of how far the standalone multiple had fallen, not how generous the bid is.

Cycle narrative. (1) The 2022 leg was the textbook builder pattern — as the 30-year mortgage roughly doubled, TMHC fell ~55% to ~$21 even as FY22 gross margin (25.4%) sat near its cycle peak, the multiple collapsing on strong earnings. (2) From that low the “peak-rates” recovery, a resilient buyer supported by mortgage-rate buydowns, and a relentless buyback (share count 129.5M→~108M over the stretch) carried the stock >3.5x to ~$74.80 by November 2024. (3) The late-2024–2025 de-rating was fundamentals catching down: an affordability ceiling, higher-for-longer rates, and gross-margin normalization pulled the stock back into the high-$50s. (4) Through 2025 into 2026 it traded a choppy $56–67 band as incentives stayed elevated and Q1-2026 adjusted home-closings gross margin fell to 20.6%, with management explicitly positioning 2026 as an investment year to reaccelerate growth in 2027+. (5) On ~30–31 May 2026 Berkshire agreed to buy the company for $72.50 cash, and the stock gapped ~+22% on 1 June. (6) Since then it has been a pinned arbitrage instrument ~0.9% below the cash price; the June sell-side downgrades reflect the capped upside, not a deterioration in the business.

Executive Summary

Taylor Morrison Home Corporation is the fifth-largest homebuilder in the United States, built by roll-up (Darling 2014, AV Homes 2018, William Lyon 2020) into a ~13,000-closings-a-year, ~$8.1 billion-revenue franchise that spans the entire buyer spectrum — entry-level, move-up, and a differentiated resort-lifestyle/55+ platform (Esplanade) — across 12 states, complemented by a captive mortgage/title arm and a small build-to-rent business. Under CEO Sheryl Palmer it has been, on the metric that matters most for a price-taking cyclical, one of the better-run public builders: a fortress balance sheet (net homebuilding debt-to-capitalization of ~18%, ~$1.8 billion of liquidity, no senior-note maturities before 2028), and a genuinely excellent capital-allocation record — a ~25% reduction in share count since 2020 (129.5M → 96.5M) funded by ~$1.6 billion of buybacks executed largely below book value, with no dividend.

That standalone analysis is now subordinate to a single fact: on May 31, 2026, TMHC agreed to be acquired by Berkshire Hathaway for $72.50 per share in cash. The stock trades at $71.85, a ~0.9% discount to the cash consideration; a special meeting is set for July 22, 2026; and the deal is expected to close in the second half of 2026. This report therefore serves two purposes: (i) to assess the probability and terms of deal completion, and (ii) to judge whether $72.50 fairly values the standalone business — i.e., whether Berkshire is paying up or picking up a bargain.

On completion, the evidence points strongly to close. The consideration is all cash with no financing condition, funded from Berkshire’s balance sheet; the only substantive regulatory gate is HSR antitrust clearance (filed June 4, 2026), where the overlap between Berkshire’s housing-adjacent holdings — Clayton Homes (manufactured housing), HomeServices (brokerage), and building-products units — and a site-built production builder is negligible; the board was unanimous on two independent fairness opinions (Goldman Sachs and Moelis); TMHC can compel Berkshire to close via specific performance; and there is no reverse termination fee because none is needed. The price emerged from a real, if narrow, market-check: a rival $71.00 cash-and-stock proposal (Party A, November 2025) and a canvass of six additional parties (B–G, January–May 2026), none of whom topped Berkshire’s “best and final” $72.50. The principal residual risks are timing (a flat February 28, 2027 outside date with no auto-extension) and a low-probability topping bid (the fiduciary-out is open, but the market was already checked and Berkshire’s balance sheet is unmatchable).

On fairness, $72.50 is best characterized as fair-but-full for a company at a cyclical inflection. It equals ~1.11x book, ~1.23x tangible book, ~9.3x trailing GAAP EPS (~8.8x adjusted), and — the number that frames the debate — it is the stock’s own 52-week high and sits below both bankers’ DCF midpoints of ~$76, in the lower-middle of their $66–$87 DCF ranges, above their public-comparable range (~$56–$68), and inside their precedent-transaction range (~$65–$89). The subtlety is that the standalone operating picture is deteriorating underneath the deal: home-closings gross margin has compressed from 24.4% (FY24) to 22.5% (FY25) to 20.0% in Q1-2026; net orders fell ~10% in FY25 and ~14% in Q1-2026; backlog collapsed ~41% to 2,819 units; incentives and mortgage-rate buydowns rose ~330 bps of revenue; and closings held flat only by liquidating backlog with lower-margin quick-move-in homes. Berkshire is buying a trough, at a trough-cycle multiple, against a management five-year plan (itself revised down between the November-2025 look and the May-2026 signing) that reaches ~$15 of EPS by 2030. If that recovery is real, $72.50 is cheap and Buffett wins; if 20% gross margins are the new normal, $72.50 is a fair clearing price for a below-book quality builder in a structurally difficult moment. Either way, public shareholders capture the certainty, not the recovery. The remainder of this memo carries no recommendation and no price target; it lays out the business, the deal, and the scenarios.

2. Business Overview

What it is. Taylor Morrison designs, builds, and sells single-family and (to a lesser extent) attached homes across the full price spectrum, and develops master-planned and lifestyle communities. Headquartered in Scottsdale, Arizona, it is the #5 U.S. public homebuilder by closings, delivering 12,997 homes in FY2025 at an average selling price (ASP) of ~$597,000, generating $8.12 billion of total revenue. Home closings are the overwhelming majority of the business — ~$7.76 billion, or ~95% of revenue — with the balance from Financial Services (~$209M), amenity/other (~$120M), and a small amount of land closings (~$37M).

How it makes money. The core model is classic merchant homebuilding: acquire and develop land, build homes, and sell them for a spread over land + hard construction + capitalized-interest cost. That spread — the home-closings gross margin — is the single most important operating variable, and it is under pressure . Two adjacent businesses matter:

• Financial Services (Taylor Morrison Home Funding mortgage, Inspired Title, and an insurance agency): a captive, high-return, counter-cyclical earnings stream. It financed ~68% of FY2025 closings, originated ~$4.1 billion of mortgages, and grew pre-tax income ~18% to $117.3 million in FY2025 — ~11% of consolidated pre-tax income — even as homebuilding profits fell. Critically, it is also the vehicle for mortgage-rate buydowns, the primary demand-stimulus incentive in the current cycle. It is the clearest quality asset in the portfolio.
• Build-to-Rent (Yardly) and Urban Form (mixed-use): sub-scale, lower-margin, and lumpy (FY2025 included one-off asset sales). Optionality, not a driver.

Segments and brands. TMHC reports three homebuilding segments — East (Florida-heavy: Tampa, Orlando, Jacksonville, Sarasota, Naples, plus Atlanta and the Carolinas), Central (Texas-led: Dallas, Houston, Austin, plus Denver, Indianapolis), and West (Arizona, California, Nevada, Pacific Northwest; the highest-ASP segment at ~$714K and ~41% of home revenue). Homes are sold primarily under the Taylor Morrison brand and the differentiated Esplanade resort-lifestyle/55+ brand (amenitized, golf/clubhouse communities carrying mid-to-high-20s% gross margins). (The legacy Darling Homes move-up brand is no longer separately named in current filings — an open question on brand rationalization.)

Buyer mix — the strategic spine. TMHC’s self-described advantage is diversification across three consumer groups: entry-level, move-up, and resort-lifestyle. The affordability squeeze of 2025–2026 has stress-tested that thesis in a revealing way: in Q1-2026, entry-level and move-up orders fell while resort-lifestyle orders rose — the higher-ASP, less-mortgage-dependent Esplanade buyer is proving resilient while the rate-sensitive first-time buyer cracks. Government-backed (FHA/VA/USDA) loans rose to 28% of TMHF originations in Q1-2026 (from ~24%), a direct tell that the marginal buyer is increasingly affordability-stretched. Verdict: a well-diversified, full-spectrum builder whose revenue quality is anchored by a genuinely valuable captive-finance arm and a differentiated resort-lifestyle niche, but whose volume base is meaningfully exposed to the most rate-sensitive slice of the housing market.

3. Industry Dynamics

Homebuilding is a structurally mediocre industry — cyclical, capital-intensive, fragmented, and price-taking — and no amount of operational excellence changes that verdict; it only determines who survives the downturns. Applying the Greenwald lens: there are no meaningful barriers to entry at the industry level (land and labor are available to all comers; buyers show near-zero brand captivity and shop on price, location, and monthly payment), and the Marathon capital-cycle lens explains the rest — high returns in the 2021–2022 boom drew capital and land into the system, and the subsequent supply of finished/spec inventory is exactly what has compressed margins industry-wide in 2025–2026.

Demand is a mortgage-rate derivative. New-home demand is set by affordability — the interplay of home prices, mortgage rates, and household income — far more than by builder-specific factors. With the 30-year mortgage stuck in the high-6%/7% range, the affordability ceiling has forced the entire group to buy demand through mortgage-rate buydowns and price incentives, which is precisely the ~330 bps of gross-margin give-up TMHC absorbed in Q1-2026. This is a sector-wide phenomenon (Toll, Lennar, D.R. Horton, PulteGroup, KB, Meritage all report the same incentive escalation), which is why builder equities de-rated in unison through 2025 — and why the affordability narrative (“Americans still can’t afford to buy”) dominates the current tape.

Scale helps at the margin, but does not create a moat. The large national builders (DHI, LEN, PHM) enjoy real, quantifiable advantages — purchasing scale on materials and trades, cost of capital, national labor relationships, and increasingly a land-light, optioned lot pipeline that lifts inventory turns and returns on capital. This is why the best-run builders can earn 20%+ ROE through a cycle. But these are relative cost/turn advantages within a commoditized product, not customer captivity or pricing power; they compress in downturns and do not prevent losses at the trough. TMHC sits in the upper-middle of this structure: larger and better-capitalized than the mid-caps (MTH, KBH, MHO, GRBK, CCS), but subscale versus the DHI/LEN/PHM triopoly on turns and land efficiency (TMHC controls ~51% of its lots off-balance-sheet versus 60–80%+ at the land-light leaders).

Regulation and geography. The binding constraints are local — entitlement/permitting timelines, water access (a live issue in TMHC’s Arizona and California markets), impact fees, and severe-weather/insurance cost (a Florida-specific pressure given the East segment’s hurricane and property-insurance exposure). Federal policy is a swing factor: the current administration’s stated focus on housing “affordability and accessibility” is a potential incremental tailwind, but management is right to characterize any relief as marginal. Verdict: a structurally unattractive, no-moat, deeply cyclical industry in which durable competitive advantage is impossible and the only defensible edges are relative cost, land efficiency, balance-sheet strength, and capital-allocation discipline. TMHC has the last two in abundance and the first two in moderation.

4. Competitive Position

Name the moat: there isn’t one — there is a quality operator in a no-moat industry. TMHC has no durable competitive advantage in the Greenwald sense. It has no customer captivity (homebuyers do not repurchase or exhibit switching costs), no network effects, no proprietary intangible that competitors cannot replicate, and no structural cost advantage over the larger nationals. The proof is in the returns: FY2025 ROIC of ~10.2% sits roughly at a reasonable estimate of the cost of capital (~9–10%), and has been falling from the boom (15.0% in FY2022). A business earning its cost of capital at the top of a cycle is, by definition, moat-less — the “advantage,” if any, must show up as durably above-cost-of-capital returns across the cycle, and TMHC’s do not.

What TMHC does have — three real, if non-moaty, edges:

1. Capital-allocation discipline (the strongest). A ~25% share-count reduction in five years, executed largely below book value, plus a fortress balance sheet — this is genuine value creation, and it is the single feature that most distinguishes TMHC from the average builder . It is a management quality advantage, not a business moat: a new owner captures it, which is exactly what Berkshire is doing.
2. The Esplanade resort-lifestyle platform. A differentiated, higher-margin (mid-to-high-20s%), more demand-resilient product for the 55+/active-adult buyer, who is wealthier and less mortgage-dependent. This is the closest thing to a defensible niche in the portfolio — amenitized master-planned communities with lot/option premiums are harder to replicate at scale and command pricing — and it is the part of the book holding up best in the current downturn. It is a mix advantage, not a moat, but it is real and growing (20+ Esplanade openings planned in 2026).
3. The captive finance arm. ~68% mortgage capture and a growing $117M pre-tax stream deepen the customer relationship and fund the incentive machine at lower cost than cash discounts. Again: a quality feature, replicated by every large peer, not a moat.

Head-to-head. Against the land-light return leaders (NVR’s optioned model, Meritage’s entry-level turns), TMHC turns inventory more slowly (~0.9–1.0x) and owns more of its land, capping ROIC. Against the luxury specialist (Toll), TMHC lacks the brand premium and the wealthy all-cash buyer, and earns a lower gross margin — but trades far cheaper (the deal’s ~1.1x book versus Toll’s ~1.7x). Against the mega-cap nationals (DHI/LEN/PHM), TMHC is subscale on purchasing and cost of capital. Verdict: a well-run, well-capitalized, full-spectrum builder with a genuinely differentiated resort-lifestyle niche and best-in-class capital allocation — but no durable competitive advantage. It is a quality operator in a commodity industry, which is precisely the kind of business that trades below book and gets acquired by a patient, low-cost-of-capital owner at the bottom of a cycle.

5. Growth History and Forward Opportunities

History — roll-up then optimize. TMHC’s scale was assembled by acquisition: Darling (2014), AV Homes (2018), and the transformational William Lyon Homes (2020, ~$2.4B), which roughly doubled the company and cemented its top-5 position. Post-2020, the strategy shifted from M&A-driven expansion to organic optimization and per-share value creation — closings grew modestly (11,495 → 12,896 → 12,997 across FY23–25), while the emphasis moved to community-count growth, margin, and aggressive share-count reduction. Revenue has been roughly flat at ~$8 billion for three years; the per-share story is far better than the aggregate, precisely because of the buyback.

The current inflection — a deliberate investment year. FY2025 into 2026 is a demand-driven trough dressed as a growth-investment year. Net orders fell ~10% in FY2025 and ~14% in Q1-2026; backlog collapsed ~41% to 2,819 units (the sharpest signal of the demand air-pocket); and closings held flat only by burning backlog with quick-move-in homes (69% of Q1-2026 closings). Management’s response is to grow the community count — opening 125+ new communities in 2026 (~30% more than 2025), targeting 365–370 active communities at year-end 2026 (+8%), with these communities contributing closings “later in the second half and into 2027.” This is the textbook builder counter-cyclical playbook: open communities into the downturn to be positioned for the recovery.

Forward opportunities. (i) Community-count-led volume recovery in 2027+ as the new openings mature — the core of management’s five-year plan, which projects revenue growing from ~$6.9B (2026E) to ~$12.1B (2030E) and EPS from $4.90 to $14.99. (ii) Esplanade expansion into new geographies (first Nevada Esplanade opening in 2026), the highest-margin growth vector. (iii) Financial Services deepening — higher capture and attach. (iv) Land-light migration — pushing the optioned-lot share above 51% to lift turns and ROIC. (v) Technology/AI cost leverage (reservation system, in-house AI apps lowering tech spend).

The credibility caveat. These are management projections prepared in a sale process, and two facts temper them: the forecast was revised down between the November-2025 Party A evaluation and the May-2026 Berkshire signing (2030E EPS cut from $15.68 to $14.99, with larger cuts to the near years), and Moelis explicitly flagged that the outer-year growth relies on communities not yet owned or specifically identified — i.e., the back-half of the plan is not land-secured. Verdict: mixed-quality growth. The historical growth was acquisition-fueled and the recent record is flat aggregate revenue rescued by an excellent per-share buyback story; the forward plan is a credible but not-yet-funded community-count recovery whose realization the public shareholder will not be around to see. The growth that matters most — the 2027+ reacceleration — is exactly the value Berkshire is capturing for cash at the trough.

6. Financial Quality

Revenue and margins — the core deterioration. Revenue has been flat at ~$8.1B (FY24 $8.17B → FY25 $8.12B), but the composition has weakened. The decisive metric, home-closings gross margin, has fallen steadily and is now compressing sharply:

The ~400 bps year-over-year collapse in Q1-2026 is driven by discounts and financing incentives (+330 bps of base home revenue), lower lot-premium revenue, adverse mix (69% quick-move-in homes; more multi-family), and inventory impairments ($28.8M in FY2025, concentrated in the West). Two quality caveats cut in both directions: reported gross margin is flattered by capitalized interest running through COGS (~$104M in FY2025), which the “adjusted” figure does not strip out — so TMHC’s margins are modestly overstated versus a fully-expensing peer; but the same incentive pressure is hitting the entire industry, so the relative position is less alarming than the absolute trend.

Returns — moderating toward the cost of capital. ROE fell from a boom 47.5% (FY22) to 24.6% (FY23), 22.3% (FY24), and 16.4% (FY25); ROIC from 15.0% to 10.2%. The direction is unambiguous: returns are normalizing down toward — and ROIC is now roughly at — the cost of capital. This is the financial signature of a no-moat cyclical past its peak.

Cash flow — real, but of low quality here. FY2025 operating cash flow was strong at $817M (versus $210M in FY2024), and free cash flow ~$777M. But this is “melting-ice-cube” cash flow: it was generated by shrinking the balance sheet — cutting land and inventory spend as demand softened — not by growth. A builder throwing off cash while orders and backlog collapse is liquidating working capital, not compounding; the cash is real but the source is contraction. Management’s own plan shows this reversing as land/development spend rises to fund the 2027+ recovery.

Balance sheet — the fortress, and the reason this is a Buffett target. This is unambiguously high quality: total debt ~$2.29B against ~$6.31B equity; net homebuilding debt-to-capitalization of ~17.8% at YE2025 (a conservative level for the sector); senior notes of ~$1.48B at a 5.1% weighted rate, 96% fixed, with no maturities before 2028 (the 2027 notes were pre-funded and redeemed in Q4-2025); a fully-undrawn $1.0B revolver; and ~$1.8B of total liquidity. Goodwill is modest (~$663M, ~10% of equity), so tangible book (~$5.63B, ~$58/share) is close to reported book. Verdict: economics do NOT durably improve with scale — returns compress toward the cost of capital as the cycle turns, and current cash flow is a byproduct of contraction rather than compounding. But the balance sheet is a genuine fortress, and it is precisely the combination of a strong balance sheet, a below-cost-of-capital equity price (~1.1x book), and depressed trough earnings that makes TMHC an ideal patient-capital acquisition — which is what happened.

7. Capital Allocation

This is TMHC’s best feature, and the crux of the Berkshire logic. Judged as a capital allocator, Palmer’s management ranks among the best in the public builder group — which is the highest-quality thing in the entire standalone story.

• Buybacks executed with discipline and at the right price. Share count fell from 129.5M (2020) to 96.5M (2025) — a ~25% reduction — funded by ~$1.6B of repurchases over five years ($376M, $128M, $348M, $381M in FY22–25; $150M in Q1-2026). Crucially, most of this was bought at or below book/tangible book value (the stock spent much of 2022–2025 between ~1.0x and ~1.5x book), making the repurchases genuinely accretive to per-share book value — which more than doubled from ~$23.84 (FY22) to ~$65 (Q1-2026). This is textbook value-accretive buyback behavior, the opposite of the buy-high pattern common among cyclicals (and, notably, cleaner on price than Toll’s near-record-multiple repurchases).
• No dividend — appropriately. For a cyclical trading below book with reinvestment optionality, prioritizing buybacks over a dividend is the correct choice; TMHC pays none.
• M&A — historically the growth engine, now dormant. The William Lyon/AV Homes/Darling roll-up built the company; management has since integrated rather than acquired, a sensible pivot to organic + per-share value.
• Land discipline. Management is migrating toward an optioned/land-banked model (~51% controlled), and has been walking away from options as demand softened (abandonment charges rising to $14.8M in FY2025) — evidence of underwriting discipline rather than chasing volume. The cost is real (land-banking carry pushed net interest expense up to $47M in FY2025), a deliberate trade of P&L cost for balance-sheet flexibility.
• Incentive alignment. Management is heavily equity-compensated; the golden-parachute disclosure (Palmer ~$38.1M, ~$19.9M of it equity) reflects a large accumulated equity stake that aligns with the $72.50 outcome. Insiders own ~1.53% and vote for the deal.

The one blemish — a deal-process conflict. Palmer personally ran the entire negotiation with Greg Abel while, per the proxy, “discussions are ongoing” with Berkshire about her continued post-closing role. This is a genuine conflict of interest — a CEO negotiating a sale price while potentially negotiating her own go-forward employment — mitigated but not eliminated by the independent board oversight, two fairness opinions, and the robust-ish market check. It is worth naming plainly, even if it did not evidently distort the outcome. Verdict: management has allocated capital intelligently — arguably excellently — with a disciplined, value-accretive buyback record, a fortress balance sheet, sensible land underwriting, and no dividend-for-optics. The record is the strongest single argument that $72.50 undervalues the franchise; it is also, ironically, exactly the quality that a patient acquirer pays to own. The lone caveat is the CEO’s unresolved conflict in the sale process.

8. Changes and Headwinds — Last Two Years

The dominant change is the pending sale (valuation is discussed in the Valuation section). On May 31, 2026 TMHC agreed to be acquired by Berkshire Hathaway for $72.50/share in cash — a board-approved, all-cash, no-financing-condition take-private, announced June 1, expected to close in 2H 2026, with a special meeting July 22, 2026 and a February 28, 2027 outside date. This supersedes everything else, including the $1.0B buyback authorization renewed in February 2026 (now moot) and the change-of-control puts (at 101%) that the merger triggers on the senior notes.

The operating headwinds that produced the trough (and the sale):

• Affordability-driven demand deterioration. The central headwind: net orders −10% (FY25) and −14% (Q1-26), a ~41% backlog collapse, cancellation rate up to 13.2% (partly because TMHC lowered required deposits to stimulate orders — a demand-quality warning), and a buyer pool skewing toward government-backed loans (28% of originations). Higher-for-longer mortgage rates, tariff/geopolitical noise, and AI-related employment anxiety were all cited by management as denting consumer confidence.
• Gross-margin compression. From 24.4% to 20.0% (Q1-26 GAAP) on rising incentives, buydowns, lower lot premiums, and adverse QMI/multi-family mix — the clearest evidence the cycle has turned.
• Rising impairments and option abandonment ($28.8M inventory impairment FY25; $14.8M abandoned deposits) and higher legal accruals ($53.3M FY25), plus a $13.3M FY25 loss on debt extinguishment.
• Operating deleverage as volume fell (SG&A/home revenue rising toward 11.4% in Q1-26).

The offsets: the fortress balance sheet, a growing counter-cyclical Financial Services stream (+18% pre-tax), a resilient resort-lifestyle segment, a deliberate community-count expansion for 2027+, and disciplined per-share capital allocation. Verdict: the last two years weakened the standalone thesis operationally — this is a business at a demand-and-margin trough, not at a steady state — which is exactly why it de-rated to ~$58 and became acquirable. The single change that now defines the thesis, the Berkshire deal, converts that trough into a ~24%-premium cash exit for public shareholders.

9. Risk Analysis (Risk Matrix)

Because the investment case is now event-driven, the risk matrix is framed around deal completion first and standalone/fundamental risks second (the latter matter primarily as the downside if the deal breaks).

Catastrophic-loss risk to a buyer at $71.85 is low given the deal: the realistic bad case is deal-break to ~$58–60 (~−17%), not a zero — the balance sheet is a fortress and there is no solvency risk. The asymmetry is the classic merger-arb shape: ~+0.9% to the ceiling versus ~−17% on a low-probability break.

10. Valuation Discussion (Embedded Expectations)

With a signed cash deal, valuation resolves into three questions: (a) what is the arb worth, (b) is $72.50 fair to standalone value, and © what is the break-downside.

(a) The arbitrage. At $71.85 versus $72.50 cash, the gross spread is ~$0.65, or ~0.9%. With a special meeting July 22, 2026, HSR filed June 4, and an expected 2H-2026 close, assume completion in ~1.5–3 months. That annualizes to a ~4–8% IRR — a thin but Berkshire-safe spread, appropriate for a deal this clean (all-cash, no financing condition, only HSR, specific performance). The market is pricing a high completion probability; the residual spread compensates for timing and the small topping-bid-less/break tail. This is an arbitrageur’s return, not an investor’s — there is no fundamental upside above $72.50.

(b) Is $72.50 fair to standalone value? Fair-but-full. The deal price equals:

• ~1.11x book / ~1.23x tangible book — below the ~1.3–1.7x that quality builders fetch in good times, but reasonable for a trough with 20% gross margins and a ~10% (cost-of-capital) ROIC.
• ~9.3x trailing GAAP EPS (~8.8x adjusted $8.24) — optically cheap, but on peak-ish/normalizing earnings, the classic cyclical value trap in reverse.
• ~14.8x management’s 2026E trough EPS ($4.90) and ~7.5x 2028E ($9.69) — cheap if the recovery arrives.

The bankers’ own work frames it precisely. Both DCFs (WACC 9.0–11.5%; terminal exit-inventory multiple ~1.0–1.3x) produced ranges of ~$66–$87, with midpoints near ~$76 — above $72.50. Moelis’s public-company comps (P/TBV 0.95–1.15x) produced ~$56–$68 — below $72.50. Precedent homebuilder transactions (P/TBV ~1.1–1.5x) produced ~$65–$89. So $72.50 lands in the lower-middle of the DCFs, above where the public market was valuing the peer group, and inside the M&A precedent range. And the plain-fact anchor: $72.50 is TMHC’s own 52-week high and only ~5% above the ~$69 median analyst target. The honest read: fair, board-defensibly so, but not a knockout — Berkshire is paying a full-but-not-generous price to a de-rated, trough-cycle equity, i.e., getting a good (not great) price on a good (not great) business. That is the Buffett signature: buy quality-enough at a fair price when the seller is motivated and the cycle is against them.

© Embedded expectations / what the deal underwrites. At $72.50 Berkshire is underwriting management’s five-year plan to largely come true — revenue to ~$12B and EPS to ~$15 by 2030 — but paying only a trough multiple for it, so the margin of safety sits in the balance sheet (~1.1x book, ~1.2x tangible) and the option on the housing-cycle recovery. For the public shareholder, the embedded expectation is simpler: the market is pricing a ~90%+ probability that $72.50 in cash arrives in 2H-2026.

(d) Break-downside. If the deal fails, the standalone equity resets toward its ~$58.50 unaffected level (arguably lower near-term on the disappointment and a still-deteriorating margin trend), i.e., ~−17% to −20% from $71.85. No price target and no recommendation — this section frames the deal economics and scenarios only.

11. Variant Perception

Consensus. With the deal signed, consensus is straightforward and largely correct: the Berkshire acquisition will close near-certainly at $72.50 in 2H-2026, so the stock is a pinned arbitrage instrument with ~0.9% of residual upside. The June sell-side downgrades to Peer/Market-Perform encode exactly this — not a fundamental bearish view, but the mechanical recognition that upside is capped at the cash price.

The strongest bull case (for the deal / for Berkshire). $72.50 is a bargain for a top-5 builder with a fortress balance sheet, a best-in-class capital allocator, a differentiated resort-lifestyle franchise, and a captive-finance arm — bought at ~1.1x book, below both bankers’ DCF midpoints, at a cyclical trough, by the ultimate patient-capital owner. The “TMHC is too cheap versus peers” thesis was correct, and Berkshire is the proof. If a topping bid were ever to emerge, this is the setup for it — though the market check makes that unlikely.

The strongest bear case (for the standalone / break scenario). Strip out the deal and TMHC is a deteriorating no-moat cyclical: gross margins in freefall (24.4% → 20.0%), orders and backlog collapsing (−14% / −41%), incentives escalating, ROIC down to its cost of capital, and cash flow that is merely the exhaust of a shrinking balance sheet. On that view, $72.50 is a gift to sellers — a full price (the 52-week high) for a business heading into a deeper trough — and the risk is not that the deal is too cheap but that, absent Berkshire, the stock is worth ~$58 and falling.

The 3–5 assumptions that matter most:

1. HSR clears without a second request (base case: yes — negligible overlap). Falsifier: an FTC/DOJ second request or timing agreement.
2. The shareholder vote passes July 22 (base case: yes). Falsifier: an unexpected large-holder revolt or ISS/Glass Lewis “against” over the Palmer conflict (low probability).
3. No MAE / Berkshire does not walk (base case: yes — specific performance, no financing out). Falsifier: a housing shock severe enough to test the MAE carve-outs (very unlikely to qualify).
4. No topping bid (base case: yes — market checked). Falsifier: an unsolicited superior proposal invoking the fiduciary-out (low probability, would be positive).
5. Standalone (break) value ~$58 — the downside anchor. Falsifier (bearish): margins break below 20% and the unaffected value proves lower.

The factor-positioning read . FactorsToday confirms the deal has become the stock: relative strength is pinned ~4% from its peak, the trailing-quarter return is enormous (~+114% annualized — the late-May deal pop, not momentum), and the residual factor signature (Home-Construction beta ~1.6, InterestRate loading −0.68) is now largely irrelevant to a fixed-cash outcome. The tape is not telling you consensus is offsides; it is telling you the equity has been fully repriced to the takeout. Variant perception, honestly stated: there is little variant left. The one non-consensus nuance worth holding is that the fundamental variant (“too cheap vs. peers”) was validated by the acquirer, not by the market — a reminder that a correct value call on a no-moat cyclical is often monetized by a buyer’s checkbook rather than a re-rating, and that the reward for owning quality-at-a-discount in a bad industry is frequently a fair-but-full cash exit at the trough.

12. Fact vs. Interpretation Table

13. Open Questions

1. HSR timing — will the FTC/DOJ clear on the initial waiting period, or issue a second request/voluntary timing agreement? (Base case: clean clearance; negligible overlap.)
2. Supplemental disclosures / litigation — will routine “disclosure” complaints or mootness-fee demands surface between the proxy and the July 22 vote? (None disclosed as of June 23, 2026.)
3. Change-of-control on the senior notes — will Berkshire refinance or leave the notes outstanding (holders have a 101% put on the merger)? Immaterial to equity holders but relevant to structure.
4. Palmer’s go-forward role — the proxy says “discussions are ongoing” but nothing is signed; does she (and the operating team) stay under Berkshire? (Berkshire’s stated intent suggests continuity.)
5. Is 20% gross margin the trough or the new normal? — the crux of the standalone/break value, and of whether Berkshire got a bargain or a fair price. Only relevant if the deal breaks.
6. Brand rationalization — the Darling Homes brand is no longer separately named; has it been folded into Taylor Morrison? (Cosmetic.)
7. Standalone unaffected value if the deal breaks — is it $58, or lower given the still-deteriorating margin trend?

14. What Must Be True

For the deal (base case) to deliver $72.50:

• HSR clears without a blocking second request — Falsification: an FTC/DOJ second request, timing agreement, or challenge (would delay past a 2H-2026 close and pressure the spread).
• The majority-of-outstanding shareholder vote passes on July 22, 2026 — Falsification: an ISS/Glass Lewis “against” over the Palmer conflict or a large-holder revolt drives the vote below 50% of outstanding (low probability given a 24% premium and two fairness opinions).
• Berkshire does not walk and no MAE is invoked — Falsification: a housing shock severe enough to satisfy the MAE definition (very unlikely given cyclical carve-outs), or Berkshire attempts to renegotiate (specific performance makes this hard).

For the standalone bull (only relevant if the deal breaks) to be right that TMHC is worth more than ~$58:

• Gross margins stabilize/recover above 22–23% and the 2027+ community-count-led volume reacceleration materializes — Falsification: two-plus more quarters of sub-21% home-closings gross margin with continued order declines would prove 20% is the new normal and cap standalone value near or below the unaffected price.

For the standalone bear (the deal-break downside) to be right:

• The affordability squeeze persists, margins break below 20%, and the no-moat cyclical re-rates toward book on a deepening trough — Falsification: a mortgage-rate decline that revives order pace and absorption, re-rating the group and lifting standalone value back toward the deal price.

15. Source Appendix

Primary sources are catalogued in Appendix B — Source Appendix below. Principal references: TMHC DEFM14A (2026-06-23), FY2025 10-K (2026-02-18), Q1-2026 10-Q (2026-04-22), FY2024/2023 10-Ks, Q1-2026 earnings call transcript (2026-04-22), and the June 2026 DEFA14A soliciting materials — all from SEC EDGAR (CIK 0001562476); supplemented by ROIC.ai (statements, ratios, enterprise value), the AZI valuation-percentile and price data, and the FactorsToday factor model. Third-party aggregated data reconciled to filings; management commentary treated as hypothesis and validated against filings and financials.

This article contains no investment recommendation and no price target outside the clearly-labeled opinion block; it discusses valuation solely as embedded expectations, deal mechanics, and scenarios. It is general information, not investment advice.

APPENDIX A — Standard Diligence Questionnaire

Taylor Morrison Home Corporation (NYSE: TMHC). Supplemental to the memo. Fact / Interpretation / Assumption labels applied where material. Context: pending all-cash acquisition by Berkshire Hathaway at $72.50/share (agreement dated 2026-05-31).

General

What thoughtful questions have other investors asked about this company? Pre-deal, the debates were: (i) is TMHC’s mid-teens ROE and ~1.1x-book valuation a bargain versus higher-multiple peers, or a fair discount for a roll-up with heavy first-time-buyer exposure? (ii) how durable is the resort-lifestyle (Esplanade) margin premium? (iii) can the land-light migration lift ROIC toward the leaders? Post-deal (May 31, 2026), the only live questions are merger-arb questions: will HSR clear cleanly, will the July 22 vote pass, could a topping bid emerge, and is $72.50 fair — the last of which Berkshire’s two fairness opinions and the market check largely answer (fair-but-full; below the bankers’ ~$76 DCF midpoints, above public comps).

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Off a high, trending toward a trough. GAAP EPS fell from a $9.06 (FY22 boom) toward $7.77 (FY25), and management’s own plan models a further drop to ~$4.90 in 2026E before recovering. Home-closings gross margin (20.0% in Q1-26) is near a cyclical low, not a high. (Fact + Interpretation.)

Driven by the external environment or internal actions? Overwhelmingly external — mortgage rates and affordability set demand; the ~41% backlog collapse and +330 bps incentive load are macro-driven. Internal actions (buybacks, land discipline, Esplanade tilt, community-count growth) have mitigated, not driven, the trajectory. (Interpretation.)

How stable are revenues? Unstable/cyclical. Flat at ~$8.1B for three years only because backlog was liquidated into closings; forward revenue is guided down to ~$6.9B (2026E) before recovering. Homebuilding revenue is inherently volatile with the rate cycle.

Outlook for products/services? Structurally sound long-run demand (housing undersupply, demographics) but cyclically pressured by affordability. Esplanade/resort-lifestyle and captive Financial Services are the most durable pieces.

How big will this market be — growing, shrinking, domestic or international? Purely domestic (12 U.S. states). The U.S. new-home market is large and structurally undersupplied but highly cyclical; TMHC’s addressable share can grow via community count and Esplanade, but the near-term direction is down before up.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More, at the trough — incentive/buydown wars as builders compete for a rate-constrained buyer; industry-wide spec inventory pressures pricing. (Interpretation.)

How profitable is the business (ROIC, ROE)? FY2025 ROE 16.4%, ROIC 10.2% — both moderating from boom peaks (47.5% / 15.0% in FY22) toward the cost of capital. (Fact.)

How profitable is the industry — how many competitors, what barriers to entry? A fragmented, low-barrier, price-taking industry; a handful of scaled nationals (DHI/LEN/PHM) earn 20%+ ROE through cost/turn/land-efficiency advantages, but there is no customer captivity and no true moat. Barriers are local (entitlement, water, insurance), not competitive.

Can the business be easily understood? Yes — merchant homebuilding: buy/develop land, build, sell for a gross-margin spread, plus a captive mortgage arm.

Can it be undermined by foreign low-cost labor? No — homes are built locally; the labor exposure is domestic trade availability/cost, and tariff-driven materials inflation (a current headwind), not offshoring.

Do brands matter? Marginally. Buyers shop location, price, and monthly payment far more than builder brand. Esplanade is the one brand with genuine pull (amenitized lifestyle communities command premiums). Otherwise brand is not a moat. (Interpretation.)

What is the nature of competition? Local, on price/incentive/location/product, against national and regional builders in each market. Currently: incentive/rate-buydown competition.

Customers’ switching costs? Effectively zero — a home is a one-time purchase with no lock-in.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Land option/land-bank positions are largely off-balance-sheet (~$3.36B of commitments; ~51% of lots controlled off-BS) — a source of flexibility, not hidden value. NOLs exist (Moelis valued them separately in the DCF). (Fact.)

Off-balance-sheet liabilities? The ~$3.36B of land option/land-banking purchase obligations ($897.8M short-term) and ~$154M of capitalized interest embedded in inventory. Manageable given ~$1.8B liquidity.

How conservative is the accounting? Reasonably conservative, with two flags: reported gross margin is flattered by capitalized interest in COGS (~$104M FY25, not stripped from “adjusted” margin), and the FY25 cancellation-rate spike was partly engineered by lowering required deposits to book orders. Impairments are recognized promptly ($28.8M FY25). (Fact + Interpretation.)

How CapEx-hungry is the business? Property/equipment capex is trivial (~$40M); the true capital intensity is land and development spend (~$2.1B FY25), the defining working-capital appetite of a builder. Land-light migration is reducing the balance-sheet intensity but shifting carry cost to the P&L.

Capital Allocation & Management

How much FCF does the business generate, and how is it used? FY2025 FCF ~$777M — but “melting-ice-cube” cash from shrinking the balance sheet, not growth. Historically deployed almost entirely to buybacks (~$1.6B over five years) and land. (Fact + Interpretation.)

Significant acquisitions recently? No — post-William Lyon (2020) the strategy is integrate-and-optimize. The only pending “transaction” is TMHC itself being acquired.

Buying back shares? Yes, aggressively and well — ~25% share-count reduction since 2020, mostly at/below book (value-accretive). Now moot post-merger.

Issuing large amounts of new shares to insiders? No — net reducer of shares; SBC is modest (~$29M FY25).

Compensation policy of directors/management? Heavily equity-weighted, driving alignment; golden-parachute totals (Palmer ~$38.1M, mostly accumulated equity) reflect a large owned stake. Conflict flag: Palmer negotiated the sale while in ongoing talks about a post-close role. (Fact.)

Motivations of management? Strong equity alignment; the deal-process conflict is the one caveat. The board (independent, two fairness opinions) provides the check.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — a Delaware C-corp, NYSE-listed common stock. Standard 1099 treatment; cash-merger proceeds are a taxable event.

Dividend policy? No dividend — capital returned entirely via buyback (the appropriate choice for a below-book cyclical). (Fact.)

How profitable is the business? Moderately, and moderating — see ROE/ROIC above. Profitability is real but cyclical and no-moat.

Is net income diverging from cash from operations? Yes, but favorably and for a mechanical reason: FY25 OCF ($817M) exceeded net income ($782M) because the company was liquidating working capital (land/inventory) as demand fell. In a recovery, OCF would fall below net income as land spend rises. (Fact + Interpretation.)

Risks & Downside

What factors would cause the stock to decline? Given the deal, essentially one: deal-break (vote failure, HSR block, Berkshire walk, or slippage past the Feb 28, 2027 outside date) → reversion to ~$58–60 (~−17%). Standalone (break) risks: further margin compression, prolonged high rates, a housing recession, Florida insurance/hurricane and AZ/CA water exposure.

Risk of a catastrophic loss? Low given the deal and a fortress balance sheet. The realistic bad case is a ~17% deal-break drawdown, not impairment of capital; no solvency risk.

Chance of a total loss? Negligible — investment-grade-quality balance sheet, no near-term maturities, and a signed all-cash deal with a well-capitalized acquirer.

Recent News & Events

Has the business environment changed recently? Yes, twice: (i) an affordability-driven demand/margin deterioration through 2025–2026 (orders −14%, backlog −41%, GM to 20%); and (ii) decisively, the May 31, 2026 Berkshire acquisition agreement at $72.50 cash. Recent sell-side downgrades (Wolfe, Raymond James, June 2026) reflect the capped upside, not fundamentals.

Significant acquisitions? TMHC as target (Berkshire). No acquisitions by TMHC.

Change in accounting policies? None material.

Recent changes — new markets, facilities, management? Community-count expansion (125+ openings in 2026, +30%), first Nevada Esplanade, continued AI/technology deployment lowering cost — all now subordinate to the pending change of ownership.

APPENDIX B — Source Appendix

Taylor Morrison Home Corporation (NYSE: TMHC). Primary sources first. All SEC filings from EDGAR, CIK 0001562476. Accessed 2026-07-11. Third-party aggregated data reconciled to filings.

Primary — SEC filings (EDGAR)

Primary — data feeds (reconciled to filings)

Secondary / cross-reference

Notes on evidence quality

• Deal facts (consideration, conditions, fees, dates, fairness ranges, projections, parachutes) are all sourced to the DEFM14A — a primary, legally-binding disclosure document.
• Operating figures are from the 10-K/10-Q; third-party aggregated figures were used for speed and cross-check and reconciled to the filings (e.g., book value, EV, share count).
• Management commentary (Q1-2026 call, the Five-Year Forecast) is treated as hypothesis, not evidence, and is explicitly flagged where it is self-interested (projections prepared in a sale process; revised down between November-2025 and May-2026).
• No insider Form 3/4/5 corpus was analyzed (frozen/moot pre-deal); low priority given the pending cash merger.